用户指南的Amivantamabb
Danielle Brazel1, Janellen Smith2, Sai-Hong Ignatius Ou2
1Department of Hematology/Oncology, Scripps Clinic/Scripps Green Hospital, La Jolla, CA, USA.
阿米万他马布为具有特定EGFR exon20ins突变的非小细胞肺癌 (NSCLC) 提供了新的治疗选择. 本综述详细介绍了其使用,有效性和管理独特的副作用,以获得最佳的患者益处.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
- 免疫学 免疫学 免疫学
背景情况:
- 在非小细胞肺癌 (NSCLC) 中表皮生长因子受体 (EGFR) exon20ins突变会对传统的氨酸激酶抑制剂产生耐药性.
- 阿米万塔马布是一种新型疗法,通过多种机制,包括免疫细胞招募,向这些耐药突变.
- 对于EGFR exon20ins NSCLC的前线和后线设置,以及对EGFR敏感性突变的组合疗法.
研究的目的:
- 提供关于amivantamab的作用机制,药理学和临床试验数据的全面审查.
- 为了指导临床医生管理与阿米万他马布治疗相关的独特毒性.
- 为医疗保健专业人员和管理NSCLC患者的研究人员提供实用参考.
主要方法:
- 对在NSCLC中使用amivantamab的已发表的临床试验数据的审查.
- 对阿米万塔马布的药理性质和作用机制的分析.
- 综合有关管理amivantamab相关副作用的信息.
主要成果:
- 阿米万塔马布在患有EGFR exon20ins突变的NSCLC中表现出有效性,已在各种环境中获得批准.
- 药物的独特机制涉及绕过抗性突变和引发免疫反应.
- 与EGFR和MET途径抑制相关的amivantamab相关毒性的管理策略至关重要.
结论:
- 阿米万他马布在治疗特定NSCLC亚型,特别是那些具有EGFR exon20ins突变的治疗中取得了重大进展.
- 有效地管理amivantamab的副作用对于最大限度地提高治疗效益和患者的治疗结果至关重要.
- 本综述为参与NSCLC向治疗的临床医生和研究人员提供了宝贵的见解.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
05:53A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
Published on: December 7, 2021
相关概念视频
Affinity and Avidity
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Therapeutic Drug Monitoring: Overview and Classification
